UK startup Resurrect Bio has successfully expanded its Series A funding round, now totaling $10.3 million. This capital infusion is earmarked for scaling its innovative technology aimed at enhancing plant immunity, helping crops self-defend against pathogens.
The company's core technology focuses on reactivating disabled immune receptors within plants. By doing so, Resurrect Bio enables crops to establish natural defenses, reducing the reliance on external chemical inputs for protection.
This development is significant for sustainable agriculture, offering a path to more resilient crops and potentially decreasing the environmental impact associated with traditional crop protection methods. It addresses the growing demand for eco-friendly farming solutions.
With the expanded Series A funding, Resurrect Bio plans to advance its technology, moving towards wider application and accessibility for farmers. The scaling efforts will concentrate on bringing this natural defense mechanism to a broader agricultural market.